Related Experiment Video
Updated: Jul 19, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Stem cell based therapies to treat muscular dystrophy
F D Price1, K Kuroda, M A Rudnicki
1Molecular Medicine Program and Center for Stem Cell and Gene Therapy, Ottawa Health Research Institute, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.
Stem cell therapies show promise for treating muscular dystrophies, a group of muscle-wasting diseases. Research focuses on improving stem cell potential, muscle homing, and immune response to regenerate muscle tissue effectively.
Area of Science:
- Neuromuscular Disorders
- Regenerative Medicine
- Stem Cell Biology
Background:
- Muscular dystrophies are progressive, debilitating muscle-wasting diseases with no effective treatments.
- Various adult and embryonic stem cell populations possess myogenic potential for treating muscular dystrophy.
- Current stem cell therapies often fail due to issues with myogenic potential, cell homing, and immune rejection.
Purpose of the Study:
- To introduce and evaluate various stem cell-based therapies for muscular dystrophy.
- To identify mechanisms controlling stem cell myogenic potential and muscle homing.
- To explore strategies for avoiding immune responses in stem cell transplantation.
Main Methods:
- Assessing myogenic potential of diverse stem cell populations.
- Investigating mechanisms of donor cell homing to muscle tissue.
- Evaluating growth factor-enhanced mesangioblast migration for muscle regeneration.
- Examining fresh satellite cell isolation techniques.
Main Results:
- Recent advancements include fresh isolation of satellite cells and use of growth factors.
- These methods promote mesangioblast migration and enhance muscle regeneration.
- Understanding stem cell homing and immune response is crucial for therapeutic success.
Conclusions:
- Stem cell-based therapies offer potential for treating muscular dystrophy.
- Further research into optimizing stem cell properties and delivery is necessary.
- Effective treatment requires addressing myogenic potential, homing, and immunogenicity.
More Related Videos
10:03Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
Published on: January 20, 2014
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic cells are...